Your browser doesn't support javascript.
loading
ImMucin: a novel therapeutic vaccine with promiscuous MHC binding for the treatment of MUC1-expressing tumors.
Kovjazin, Riva; Volovitz, Ilan; Kundel, Yulia; Rosenbaum, Eli; Medalia, Gal; Horn, Galit; Smorodinsky, Nechama I; Brenner, Baruch; Carmon, Lior.
Affiliation
  • Kovjazin R; Vaxil BioTherapeutics Ltd., 13 Einstein Street, Weizmann Science Park, Nes-Ziona 74036, Israel.
Vaccine ; 29(29-30): 4676-86, 2011 Jun 24.
Article in En | MEDLINE | ID: mdl-21570434
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Mucin-1 / Cancer Vaccines / Histocompatibility Antigens / Immunotherapy / Neoplasms Type of study: Prognostic_studies Limits: Aged / Animals / Female / Humans / Male / Middle aged Language: En Journal: Vaccine Year: 2011 Document type: Article Affiliation country: Israel Country of publication: Países Bajos
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Mucin-1 / Cancer Vaccines / Histocompatibility Antigens / Immunotherapy / Neoplasms Type of study: Prognostic_studies Limits: Aged / Animals / Female / Humans / Male / Middle aged Language: En Journal: Vaccine Year: 2011 Document type: Article Affiliation country: Israel Country of publication: Países Bajos